Infliximab
Showing 26 - 50 of 774
COVID-19 Trial in Jena (Infliximab, Standard of Care)
Recruiting
- COVID-19
- Infliximab
- Standard of Care
-
Jena, GermanyJena University Hospital
Aug 10, 2022
A Cohort Study Comparing IFX to CS for Moderate to Severe UC
Recruiting
- Moderate to Severe Ulcerative Colitis
- Infliximab
- Corticosteroid
-
Guandong, ChinaThe Sixth Affiliated Hospital, Sun Yat-sen University
Nov 22, 2022
Glaucoma Following Surgery Trial in Montréal (Topical infliximab, No topical infliximab)
Recruiting
- Glaucoma Following Surgery
- Topical infliximab
- No topical infliximab
-
Montréal, Quebec, CanadaCentre Hospitalier de l'Université de Montréal
Jul 4, 2022
Ulcerative Colitis Trial in Melbourne (Infliximab)
Active, not recruiting
- Ulcerative Colitis
- Infliximab
-
Melbourne, Victoria, AustraliaAustin Health
Jun 19, 2022
Exclusive Enteral Nutrition, Ulcerative Colitis, Children Trial (exclusive enteral nutrition, regular food)
Not yet recruiting
- Exclusive Enteral Nutrition
- +2 more
- exclusive enteral nutrition
- regular food
- (no location specified)
Dec 5, 2022
Crohn Disease Trial in United States (RoadMAB, Infliximab)
Not yet recruiting
- Crohn Disease
- RoadMAB
- Infliximab
-
Los Angeles, California
- +9 more
Dec 19, 2022
Tocilizumab Versus Tocilizumab/Infliximab in COVID-19-associated
Completed
- Covid19
- +2 more
- Tocilizumab
- Infliximab
-
Cairo, Please Select, EgyptTeachers Hospital
Jul 19, 2022
Crohn's Disease Trial in Warszawa (CT-P13 SC (Infliximab), Placebo SC)
Active, not recruiting
- Crohn's Disease
- CT-P13 SC (Infliximab)
- Placebo SC
-
Warszawa, PolandWIP Warsaw IBD Point Profesor Kierkus
Dec 6, 2022
Aneurysm, Stroke, Vasculitis Trial in San Francisco (Infliximab)
Enrolling by invitation
- Aneurysm
- +3 more
- Infliximab
-
San Francisco, CaliforniaUCSF Medical Center
Apr 25, 2022
Schizophrenia Trial in Atlanta (Infliximab, Placebo)
Not yet recruiting
- Schizophrenia
- Infliximab
- Placebo
-
Atlanta, Georgia
- +1 more
Apr 10, 2023
Biomarkers to Predict and Monitor Response to Infliximab
Recruiting
- Crohn Disease
- Infliximab
-
Boston, MassachusettsMassGeneral for Children
Apr 5, 2022
Depression Trial in Atlanta (Infliximab, Placebo)
Active, not recruiting
- Depression
- Infliximab
- Placebo
-
Atlanta, GeorgiaEmory University
Jan 23, 2023
Sub-cutaneous Infliximab in Inflammatory Rheumatic Disease
Not yet recruiting
- Rheumatoid Arthritis
- +2 more
- collection of clinical parameters and blood sample
-
Paris, IDF, FranceRheumatology Department, Cochin Hospital
Jun 17, 2022
IBD Trial in Leuven (Infliximab)
Recruiting
- Inflammatory Bowel Diseases
- Infliximab
-
Leuven, Vlaanderen, BelgiumUZ Leuven
Feb 11, 2022
Metastatic Melanoma Trial in Boston (Pembrolizumab, Infliximab, Placebo)
Recruiting
- Metastatic Melanoma
- Pembrolizumab
- +2 more
-
Boston, MassachusettsMassachusetts General Hospital Cancer Center
Apr 6, 2022
Irritable Bowel Disease Trial in Cairo (Infliximab, Adalimumab)
Recruiting
- Irritable Bowel Disease
- Infliximab
- Adalimumab
-
Cairo, EgyptTropical Medicine department, Ain Shams University Hospitals.
Mar 12, 2022
Fate in Fistulizing Crohn's Disease in a Pediatric Population
Active, not recruiting
- Crohn Disease
- Infliximab
- Stomy
- (no location specified)
Feb 25, 2023
Colitis, Ulcerative Trial in Amsterdam (Infliximab)
Recruiting
- Colitis, Ulcerative
- Infliximab
-
Dublin, Ireland
- +6 more
Dec 2, 2022
Ulcerative Colitis Trial (Appendectomy, Infliximab)
Not yet recruiting
- Ulcerative Colitis
- Appendectomy
- Infliximab
- (no location specified)
Jun 27, 2023
IBD Trial in Trieste (Infliximab)
Recruiting
- Inflammatory Bowel Diseases
- Infliximab
-
Trieste, ItalyInstitute for Maternal and Child Health - IRCCS "Burlo Garofolo"
Mar 18, 2022
Melanoma Trial in Toulouse (Nivolumab+Ipilimumab in combination with Anti TNF-a Certolizumab, Nivolumab+Ipilimumab in
Active, not recruiting
- Melanoma
- Nivolumab+Ipilimumab in combination with Anti TNF-α Certolizumab
- Nivolumab+Ipilimumab in combination with Anti TNF-α Infliximab
-
Toulouse, FranceInstitut Claudius Regaud IUCT-ONCOPOLE
Nov 18, 2022
Crohn Disease Trial (Azathioprine + infliximab, Intestinal resection)
Not yet recruiting
- Crohn Disease
- Azathioprine + infliximab
- Intestinal resection
- (no location specified)
Oct 14, 2022
Ulcerative Colitis, Infliximab, Children Trial in Shanghai (Infliximab, Corticosteroids)
Recruiting
- Ulcerative Colitis
- +2 more
- Infliximab
- Corticosteroids
-
Shanghai, Shanghai, ChinaChildren's Hospital of Fudan University
Feb 5, 2022
Uveitis, Infliximab Trial (infliximab)
Active, not recruiting
- Uveitis
- Infliximab
- infliximab
- (no location specified)
Oct 28, 2021
Pediatric HSCT Recipients With aGVHD: Prospective Observational
Recruiting
- Graft Versus Host Disease, Acute
- Hematopoietic Stem Cell Transplantation
-
Trieste, ItalyIRCCS Burlo Garofolo
Apr 30, 2022